Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tilray (DE:2HQ)
XETRA:2HQ
Tilray (2HQ) Stock Price & Analysis
7 Followers
2HQ Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€1.38 - €3.22
Previous Close€1.67
Volume26.60K
Average Volume (3M)78.73K
Market Cap
€1.33B
Enterprise Value€1.44B
Total Cash (Recent Filing)$464.85M
Total Debt (Recent Filing)$562.71M
Price to Earnings (P/E)-3.6
Beta1.70
Next Earnings
Jul 24, 2024EPS Estimate
-€0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.47
Shares Outstanding742,725,148
10 Day Avg. Volume48,052
30 Day Avg. Volume78,733
Standard Deviation0.30
R-Squared0.04
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)3.44
Price to Sales (P/S)6.77
Price to Cash Flow (P/CF)-21.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.22
Enterprise Value/Gross Profit9.81
Enterprise Value/Ebitda-1.14
Forecast
1Y Price Target
€2.09Price Target Upside24.60% Upside
Rating ConsensusHold
Number of Analyst Covering7
Tilray News
Bulls Say, Bears Say
Bulls Say
Cannabis SalesCannabis net sales have exceeded anticipations, indicating a stronger market position.
EarningsTilray's second quarter financial performance showcases a net revenue surpassing analyst expectations.
Sales GrowthImpressive sales growth in constant currency terms significantly outpaces analyst projections.
Bears Say
Earnings PerformanceAdjusted EBITDA missed analyst's expectations.
Profitability ConcernsBeverage alcohol adjusted gross margin was significantly reduced due to recent craft brand acquisitions.
Quarterly ResultsThe company reported a slight miss in their Q2 financial results.
---
Options Prices
Currently, No data available
---
Ownership Overview
1.47% Insiders
0.59% Mutual Funds
3.90% Other Institutional Investors
94.05% Public Companies and
Individual Investors
2HQ FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was €1.38 and its highest was €3.22 in the past 12 months.
What is Tilray’s market cap?
Currently, no data Available
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Jul 24, 2024 which is in 90 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Apr 09, 2024. The company reported -€0.113 earnings per share for the quarter, missing the consensus estimate of -€0.047 by -€0.066.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is -€0.03.
How many shares outstanding does Tilray have?
Tilray has 774,028,560 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -€0.113 in its last earnings report, missing expectations of -€0.047. Following the earnings report the stock price went down -19.746%.
Which hedge fund is a major shareholder of Tilray?
Among the largest hedge funds holding Tilray’s share is Aristeia Capital LLC. It holds Tilray’s shares valued at 229K.
---
Tilray Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€2.09 (24.60% Upside)
€2.09 (24.60% Upside)
Blogger Sentiment
Bullish
DE:2HQ Sentiment 63%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-20.00%
12-Months-Change
Fundamentals
Return on Equity
-10.41%
Trailing 12-Months
Asset Growth
-3.73%
Trailing 12-Months
Company Description
Tilray
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.
---
2HQ Earnings Call
Q3 2024
0:00 / 0:00
---
2HQ Stock 12 Months Forecast
Average Price Target
€2.09
▲(24.60% Upside)
Technical Analysis
Best Analysts Covering 2HQ
1 Year
1 Year Success Rate
0/19 ratings generated profit
1 Year Average Return
-47.35%
reiterated a buy rating 4 months ago
Copying Vivien Azer's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -47.35% per trade.
---